Johannes Haybaeck
Overview
Explore the profile of Johannes Haybaeck including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
281
Citations
4784
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Krumbein M, Oberman F, Cinnamon Y, Golomb M, May D, Vainer G, et al.
Commun Biol
. 2023 Dec;
6(1):1229.
PMID: 38052926
The IGF2BP family of RNA binding proteins consists of three paralogs that regulate intracellular RNA localization, RNA stability, and translational control. Although IGF2BP1 and 3 are oncofetal proteins, IGF2BP2 expression...
12.
Nenning K, Gesperger J, Furtner J, Nemc A, Roetzer-Pejrimovsky T, Choi S, et al.
Neurooncol Adv
. 2023 Nov;
5(1):vdad136.
PMID: 38024240
Background: The prognostic roles of clinical and laboratory markers have been exploited to model risk in patients with primary CNS lymphoma, but these approaches do not fully explain the observed...
13.
Cyran A, Kleinegger F, Nass N, Naumann M, Haybaeck J, Arens C
Cancers (Basel)
. 2023 Nov;
15(22).
PMID: 38001610
Drug resistance is a common cause of therapy failure in head and neck squamous cell carcinoma (HNSCC). One approach to tackling it is by targeting fundamental cellular processes, such as...
14.
Schatz C, Qerimi A, Haybaeck J
Pathologie (Heidelb)
. 2023 Nov;
44(Suppl 3):229-231.
PMID: 37987811
The situation regarding digital pathology in Austria is manageable compared to other countries. Active Austrian examples are the consortium EMPAIA, the private-public partnership Bigpicture, the Austrian Society for Clinical Pathology...
15.
Krassnig S, Leber S, Orthmann A, Golob-Schwarzl N, Huber H, Wohlrab C, et al.
J Neurooncol
. 2023 Nov;
165(1):91-100.
PMID: 37907716
Purpose: Since glioma therapy is currently still limited until today, new treatment options for this heterogeneous group of tumours are of great interest. Eukaryotic initiation factors (eIFs) are altered in...
16.
Rauchenwald T, Handle F, Connolly C, Degen A, Seifarth C, Hermann M, et al.
Inflamm Regen
. 2023 Oct;
43(1):53.
PMID: 37904253
Background: Chronic non-healing wounds pose a global health challenge. Under optimized conditions, skin wounds heal by the formation of scar tissue. However, deregulated cell activation leads to persistent inflammation and...
17.
Mohamed M, Haybaeck J, Wu H, Su H, Bartneck M, Lin C, et al.
JHEP Rep
. 2023 Oct;
5(11):100854.
PMID: 37791376
Background & Aims: Cholestatic liver injury is associated with c-Jun N-terminal kinases (JNK) activation in distinct cell types. Its hepatocyte-specific function during cholestasis, however, has not yet been established. Therefore,...
18.
Driva T, Schatz C, Haybaeck J
Biomolecules
. 2023 Aug;
13(8).
PMID: 37627318
Ovarian clear cell (OCCC) and endometrioid (EnOC) carcinomas are often subsumed under the umbrella term "endometriosis-associated ovarian cancer" (EAOC), since they frequently arise from ectopic endometrium settled in the ovaries....
19.
Egidi M, Krug S, Haybaeck J, Michl P, Griesmann H
Br J Cancer
. 2023 Aug;
129(8):1225-1237.
PMID: 37620408
Background: Pancreatic neuroendocrine tumors (PNETs) represent a distinct hypervascularized tumor entity, often diagnosed at metastatic stage. Therapeutic efficacy of anti-angiogenic multi-kinase inhibitors is frequently limited by primary or acquired resistance...
20.
Zhou Z, Li C, Wang Z, Haybaeck J, Zhang C
Expert Rev Mol Diagn
. 2023 Jul;
23(7):583-588.
PMID: 37409376
Introduction: Due to the limited number of studies focusing on the optimal treatment of multiple Krukenberg tumor (KT)-gastric carcinoma (KT - GC), it is necessary to conduct large-scale studies to...